Examination of Efficacy and Safety of Baricitinib in RA Patients
Status:
Recruiting
Trial end date:
2025-11-20
Target enrollment:
Participant gender:
Summary
The aim of this study is to examine the efficacy and adverse events in the following 3 groups
in rheumatoid arthritis patients:
1. Baricitinib treatment for 12 months
2. Biologics treatment for 12 months
3. Tofacitinib treatment for 12 months